Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
450K
-
Shares change
-
-113K
-
Total reported value, excl. options
-
$10.8M
-
Value change
-
-$4.91M
-
Number of sells
-
-1
-
Price
-
$23.92
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q2 2023
2 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q2 2023.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 450K shares
.
Largest 2 shareholders include Knoll Capital Management, LLC (450K shares) and Liontrust Investment Partners LLP (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.